Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R212-6). We employs the AAV (T7-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the single base pair Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R212-6
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Single base pair
Carrier Type
AAV
Transformation Accuracy
0.94
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.